Equifax (EFX) Stock Forecast & Price Target

$252.92 +5.84 (+2.36%)

(As of 11/21/2024 ET)

Equifax - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
4

Buy
15

Based on 19 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$306.74
21.28% Upside

According to the 19 analysts' twelve-month price targets for Equifax, the average price target is $306.74. The highest price target for EFX is $380.00, while the lowest price target for EFX is $267.00. The average price target represents a forecasted upside of 21.28% from the current price of $252.92.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

EFX Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	16 Buy rating(s)	13 Buy rating(s)	8 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$306.74	$310.47	$292.00	$216.00
Forecasted Upside	21.28% Upside	14.11% Upside	-3.37% Downside	2.59% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Business Services Companies	S&P 500
Consensus Rating Score	2.79	2.68	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	21.28% Upside	331.97% Upside	8.51% Upside
News Sentiment Rating	Neutral News See Recent EFX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/20/2024	Stifel Nicolaus 4 of 5 stars		Lower Target	Buy ➝ Buy	$305.00 ➝ $284.00	+16.43%
11/19/2024	JPMorgan Chase & Co. 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$304.00 ➝ $283.00	+16.93%
11/19/2024	Oppenheimer 3 of 5 stars		Lower Target	Outperform ➝ Outperform	$315.00 ➝ $286.00	+16.60%
10/28/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$350.00 ➝ $350.00	+29.68%
10/18/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
10/18/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$290.00 ➝ $333.00	+18.01%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
10/1/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$360.00	+22.51%
9/19/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Grobler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$310.00	+4.18%
9/13/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$300.00 ➝ $380.00	+24.12%
9/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$250.00 ➝ $271.00	-9.05%
8/20/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$277.00 ➝ $307.00	+4.23%
7/24/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$263.00 ➝ $304.00	+15.32%
7/18/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$255.00 ➝ $286.00	+10.34%
7/9/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Wurtzel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$275.00	+13.97%
2/13/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$210.00 ➝ $310.00	+21.21%
2/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$270.00 ➝ $285.00	+14.38%
1/11/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$272.00	+11.10%
12/18/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$200.00 ➝ $315.00	+28.78%
12/8/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$218.00 ➝ $267.00	+19.05%
11/17/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
7/21/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$235.00 ➝ $250.00	+15.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:17 PM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 1, 2024. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. reported higher-than-expected EPS for the quarter, indicating strong financial performance.
The company's revenue for the quarter exceeded consensus estimates, showing positive growth.
Equifax Inc. has a healthy net margin of 10.67% and a return on equity of 18.88%, reflecting efficient operations and profitability.
Recent insider selling by EVP Carla Chaney could indicate confidence in the company's future performance.
Equifax Inc. has received positive ratings from analysts, with price targets indicating potential growth.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

The dividend payout ratio of Equifax Inc. is currently at 34.74%, which may limit potential reinvestment for growth.
Despite positive analyst ratings, there is always a level of uncertainty in the market that could impact stock performance.
Recent insider selling activity, such as EVP Carla Chaney selling shares, could raise concerns about future prospects.
Market conditions and regulatory changes in the credit services industry could affect Equifax Inc.'s operations and profitability.
Investors should carefully monitor any developments related to data breaches or cybersecurity risks that could impact Equifax Inc.'s reputation and financial stability.

EFX Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $306.74, with a high forecast of $380.00 and a low forecast of $267.00.
: 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EFX shares.
: According to analysts, Equifax's stock has a predicted upside of 21.28% based on their 12-month stock forecasts.
: Over the previous 90 days, Equifax's stock had 1 upgrade by analysts.
: Equifax has been rated by research analysts at Barclays, BNP Paribas, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer, Robert W. Baird, Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.79 while the average consensus rating score for "business services" companies is 2.68. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

This page (NYSE:EFX) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target